2024 Q3 Form 10-Q Financial Statement

#000165495424010210 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $109.9K
YoY Change -36.28%
Cash & Equivalents $109.9K
Short-Term Investments
Other Short-Term Assets $92.12K
YoY Change 179.58%
Inventory
Prepaid Expenses $92.12K
Receivables
Other Receivables
Total Short-Term Assets $202.0K
YoY Change -1.65%
LONG-TERM ASSETS
Property, Plant & Equipment $14.21M
YoY Change 0.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $528.6K
YoY Change 0.0%
Total Long-Term Assets $14.74M
YoY Change 0.53%
TOTAL ASSETS
Total Short-Term Assets $202.0K
Total Long-Term Assets $14.74M
Total Assets $14.94M
YoY Change 0.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $42.07K
YoY Change -45.24%
Accrued Expenses $6.696K
YoY Change 59.28%
Deferred Revenue
YoY Change
Short-Term Debt $346.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $575.3K
YoY Change 16.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $149.4K
YoY Change 5.0%
Total Long-Term Liabilities $149.4K
YoY Change 5.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $575.3K
Total Long-Term Liabilities $149.4K
Total Liabilities $724.8K
YoY Change 13.63%
SHAREHOLDERS EQUITY
Retained Earnings -$77.34M
YoY Change 1.81%
Common Stock $190.0K
YoY Change 18.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.22M
YoY Change
Total Liabilities & Shareholders Equity $14.94M
YoY Change 0.5%

Cashflow Statement

Concept 2024 Q3 2024 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5935000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6035000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
38402384 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32720000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
44437384 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001288750
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189996152 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
174246152 shares
CY2024Q2 tlrs Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
0
tlrs Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
0
CY2023Q2 tlrs Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
0
CY2023Q2 us-gaap Depreciation
Depreciation
0 usd
us-gaap Depreciation
Depreciation
0 usd
us-gaap Depreciation
Depreciation
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.17
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.18
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.18
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34055
dei Entity Registrant Name
EntityRegistrantName
TIMBERLINE RESOURCES CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-0291227
dei Entity Address Address Line1
EntityAddressAddressLine1
9030 NORTH HESS ST.
dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 161
dei Entity Address City Or Town
EntityAddressCityOrTown
HAYDEN
dei Entity Address State Or Province
EntityAddressStateOrProvince
ID
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
83835
dei City Area Code
CityAreaCode
208
dei Local Phone Number
LocalPhoneNumber
664-4859
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
TLRS
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
189996152 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109859 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98224 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
92118 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8130 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
201977 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
106354 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14209178 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14155178 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
528643 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
528643 usd
CY2024Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1200 usd
CY2023Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
5700 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
529843 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
534343 usd
CY2024Q2 us-gaap Assets
Assets
14940998 usd
CY2023Q3 us-gaap Assets
Assets
14795875 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
42074 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
83867 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6696 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6245 usd
CY2024Q2 tlrs Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
6568 usd
CY2023Q3 tlrs Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
0 usd
CY2024Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
173995 usd
CY2023Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
123943 usd
CY2024Q2 tlrs Notes Payable Related Party Current And Noncurrent
NotesPayableRelatedPartyCurrentAndNoncurrent
346000 usd
CY2023Q3 tlrs Notes Payable Related Party Current And Noncurrent
NotesPayableRelatedPartyCurrentAndNoncurrent
0 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
575333 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
214055 usd
CY2024Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
149440 usd
CY2023Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
144040 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
149440 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
144040 usd
CY2024Q2 us-gaap Liabilities
Liabilities
724773 usd
CY2023Q3 us-gaap Liabilities
Liabilities
358095 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189996152 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
174246152 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
189996 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
174246 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91362351 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90744432 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77336122 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-76480898 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
14216225 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
14437780 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14940998 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14795875 usd
CY2024Q2 us-gaap Exploration Expense
ExplorationExpense
61634 usd
CY2023Q2 us-gaap Exploration Expense
ExplorationExpense
108761 usd
us-gaap Exploration Expense
ExplorationExpense
178093 usd
us-gaap Exploration Expense
ExplorationExpense
727827 usd
CY2024Q2 us-gaap Salaries And Wages
SalariesAndWages
60984 usd
CY2023Q2 us-gaap Salaries And Wages
SalariesAndWages
88363 usd
us-gaap Salaries And Wages
SalariesAndWages
214602 usd
us-gaap Salaries And Wages
SalariesAndWages
278840 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
64341 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
58393 usd
us-gaap Professional Fees
ProfessionalFees
161374 usd
us-gaap Professional Fees
ProfessionalFees
171904 usd
CY2024Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
38787 usd
CY2023Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
40821 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
94006 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
125739 usd
CY2024Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
76528 usd
CY2023Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
80477 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
213058 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
313156 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
302274 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
376815 usd
us-gaap Operating Expenses
OperatingExpenses
861133 usd
us-gaap Operating Expenses
OperatingExpenses
1617466 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-302274 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-376815 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-861133 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1617466 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
12126 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
648 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
16298 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
6931 usd
CY2024Q2 tlrs Interest Expenses Related Party
InterestExpensesRelatedParty
6568 usd
CY2023Q2 tlrs Interest Expenses Related Party
InterestExpensesRelatedParty
16381 usd
tlrs Interest Expenses Related Party
InterestExpensesRelatedParty
6568 usd
tlrs Interest Expenses Related Party
InterestExpensesRelatedParty
47031 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
1442 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
1049 usd
us-gaap Interest Expense
InterestExpense
3848 usd
us-gaap Interest Expense
InterestExpense
2530 usd
CY2024Q2 us-gaap Other Income
OtherIncome
0 usd
CY2023Q2 us-gaap Other Income
OtherIncome
56 usd
us-gaap Other Income
OtherIncome
27 usd
us-gaap Other Income
OtherIncome
513 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4116 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16726 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5909 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-42117 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-298158 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-393541 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-855224 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1659583 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-298158 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-393541 usd
us-gaap Net Income Loss
NetIncomeLoss
-855224 usd
us-gaap Net Income Loss
NetIncomeLoss
-1659583 usd
tlrs Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
CY2024Q2 tlrs Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
189996152 shares
CY2023Q2 tlrs Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
159676152 shares
tlrs Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
184822794 shares
tlrs Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
159676152 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
14437780 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3669 usd
CY2023Q4 tlrs Common Stock And Warrants Issued For Cash Amount
CommonStockAndWarrantsIssuedForCashAmount
630000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-232287 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
14839162 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-324779 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
14514383 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-298158 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
14216225 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
15814762 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
51708 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-881543 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
14984927 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11087 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-384499 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
14611515 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11084 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-393541 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
14229058 usd
us-gaap Profit Loss
ProfitLoss
855224 usd
us-gaap Profit Loss
ProfitLoss
1659583 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3669 usd
us-gaap Share Based Compensation
ShareBasedCompensation
73879 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
5400 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
5145 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
83988 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
14502 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-4500 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-41793 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-563167 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
451 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-18010 usd
tlrs Increase Decrease In Accrued Interest Related Party
IncreaseDecreaseInAccruedInterestRelatedParty
6568 usd
tlrs Increase Decrease In Accrued Interest Related Party
IncreaseDecreaseInAccruedInterestRelatedParty
47032 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
50052 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3663 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-910365 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2132869 usd
us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
54000 usd
us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
54000 usd
us-gaap Payments To Acquire Mining Assets
PaymentsToAcquireMiningAssets
0 usd
us-gaap Payments To Acquire Mining Assets
PaymentsToAcquireMiningAssets
79302 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-133302 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
630000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
346000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
976000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
11635 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2266171 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98224 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2438587 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109859 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
172416 usd
us-gaap Loans Assumed1
LoansAssumed1
500000 usd
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
26785000 shares
CY2024Q2 us-gaap Mineral Rights
MineralRights
14157701 usd
CY2023Q3 us-gaap Mineral Rights
MineralRights
14103701 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
175305 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
175305 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
123828 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
123828 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14209178 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14155178 usd
CY2024Q2 us-gaap Depreciation
Depreciation
0 usd
tlrs Companymergeragreement Textblock
CompanymergeragreementTextblock
<p style="font-size:10pt;font-family:times new roman;margin:0px"><strong><em>NOTE 5 – MERGER AGREEMENT</em></strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 16, 2024, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with McEwen Mining Inc., a Colorado corporation (“McEwen”), and Lookout Merger Sub, Inc., a Delaware corporation and direct subsidiary of McEwen (“Merger Sub”). The Merger Agreement provides that, among other things and subject to the terms and conditions of the Merger Agreement, Merger Sub will merge with and into the Company, with the Company surviving and continuing as the surviving corporation as a direct, wholly owned subsidiary of McEwen (such transaction, the “Merger”).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At the effective date of the Merger, each outstanding share of common stock of the Company will be converted into the right to receive 0.01 of a share of common stock of McEwen. The Company has called for a special meeting of its stockholders to consider and approve the Merger, to be held on August 16, 2024. If approved by the Company’s stockholders, the Merger is expected to be consummated in the third calendar quarter of 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Bridge Financing</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In connection with the Merger Agreement, on April 16, 2024, the Company and McEwen entered into a note whereby McEwen would provide the Company with loans totaling approximately $500,000, as the Company may request from time to time (the “Note”). For each calendar month, McEwen is not obligated to make any loan that would cause the aggregate amount of loans for such calendar month to exceed the lesser of (i) the monthly budget for each calendar month provided by the Company to McEwen in advance of such applicable month from time to time or (ii) the Company’s monthly budget as provided on a schedule to the Note. The Note bears interest at a per annum rate of 15%, accruing monthly, and matures on October 15, 2024, <span style="text-decoration:underline">provided</span>, that if the Merger Agreement is terminated by the Company, then the Maturity Date shall be 5 business days following the effective date of such termination; provided further, however, that if the Merger Agreement is terminated by McEwen, then the Maturity Date shall be 20 calendar days following the effective date of such termination. The Company has the right to prepay the Note, in whole or in part, at any time without penalty.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the nine months ended June 30, 2024, the Company received a total of $346,000 of the bridge financing. At June 30, 2024, the balance of the note payable – related party is $346,000. During the three and nine months ended June 30, 2024, $6,568 has been accrued for interest and is included in accrued interest payable – related party on the condensed consolidated balance sheet.</p>
CY2024Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
26785000 usd
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.07
us-gaap Debt Instrument Term
DebtInstrumentTerm
P2Y8M8D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8335000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.18
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2300000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.18
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6035000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.17
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
100000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.10
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5935000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.18
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5935000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.18
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y1M6D
tlrs Mineral Properties Annual Fees
MineralPropertiesAnnualFees
285523 usd

Files In Submission

Name View Source Status
0001654954-24-010210-index-headers.html Edgar Link pending
0001654954-24-010210-index.html Edgar Link pending
0001654954-24-010210.txt Edgar Link pending
0001654954-24-010210-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlrs-20240630.xsd Edgar Link pending
tlrs_10q.htm Edgar Link pending
tlrs_10qimg3.jpg Edgar Link pending
tlrs_10qimg4.jpg Edgar Link pending
tlrs_ex311.htm Edgar Link pending
tlrs_ex312.htm Edgar Link pending
tlrs_ex321.htm Edgar Link pending
tlrs_ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
tlrs-20240630_lab.xml Edgar Link unprocessable
tlrs-20240630_pre.xml Edgar Link unprocessable
tlrs_10q_htm.xml Edgar Link completed
tlrs-20240630_cal.xml Edgar Link unprocessable
tlrs-20240630_def.xml Edgar Link unprocessable